Market Cap
A$97.0 Million
AUD as of Feb. 1, 2022
US$69.3 Million
| Company | Market Cap (USD) | 
|---|---|
|  Abbott | $233.33 B | 
|  Boston Scientific Corporation | $154.34 B | 
|  Stryker | $151.06 B | 
|  Medtronic | $113.25 B | 
|  Edwards Lifesciences Corporation | $45.05 B | 
| Company | Market Cap (USD) | 
|---|---|
|  Lilly | $699.59 B | 
|  Johnson & Johnson | $374.29 B | 
|  AbbVie | $336.94 B | 
|  Novo Nordisk | $309.91 B | 
|  UnitedHealth Group | $279.90 B | 
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
 Australia
                        
                    
                    
                        languages
                        Healthcare
                    
                        languages
                        Medical Devices
                            Australia
                        
                    
                    
                        languages
                        Healthcare
                    
                        languages
                        Medical Devices
                     Australia Healthcare
                                Australia Healthcare
                        
                             Australia Medical Devices
                            Australia Medical Devices
                    
                    The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.